BioCatalyst

Bimekizumab — catalyst calendar

2 verified catalyst event(s) referencing Bimekizumab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-28
in 1mo
ESTIMATED
 READOUT
A Study to Test the Long-term Treatment of Bimekizumab in Study Participants Wit
Phase 3 · Hidradenitis Suppurativa
 UCB Biopharma SRL Bimekizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-08-07
in 2mo
ESTIMATED
 READOUT
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizum
Phase 3 · Axial Spondyloarthritis, Ankylosing Spondylitis
 UCB Biopharma SRL Bimekizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.